Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

364-Day Credit Agreement [Amended and Restated]

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

364-Day Credit Agreement [Amended and Restated]

Entities:

ABN AMRO Bank N.V.; Bank of Nova Scotia; Baxter International Inc.; Chase Manhattan Bank; Chase Securities Inc.; Edwards Lifesciences Corp.; First Union National Bank; Fleet National Bank; Wachovia Bank, NA; Bank of America, NA; Bank of New York

Date:

2001

Size:

Preview shows 9KB of 208KB total

Price:

$65

ID:

#302752

 

 

► Loans ► Credit ► Multi-Year ► 364-Day Credit Agreements
► Financial
► Financial ► Money Center Banks
► Financial ► Regional Banks
► Biotechnology & Drugs
► Biotech & Drugs ► Surgical & Medical Instruments & Apparatus

 

 

Start of Preview


                                   Dated as of


March 29, 2001

Among

EDWARDS LIFESCIENCES CORPORATION
as Borrower

The Lenders Party Hereto

THE CHASE MANHATTAN BANK
as Administrative Agent

CREDIT SUISSE FIRST BOSTON
as Syndication Agent

and

THE BANK OF NOVA SCOTIA
as Documentation Agent

---------------------------

JPMORGAN,
a division of Chase Securities Inc.,
as Advisor, Lead Arranger and Bookrunner

================================================================================

{PAGE}

TABLE OF CONTENTS

Page

ARTICLE I

Definitions

SECTION 1.01. Defined Terms...................................................1
SECTION 1.02. Classification of Loans and Borrowings.........................11
SECTION 1.03. Terms Generally................................................11
SECTION 1.04. Accounting Terms; GAAP.........................................11

ARTICLE II

The Credits

SECTION 2.01. Commitments....................................................11
SECTION 2.02. Loans and Borrowings...........................................12
SECTION 2.03. Requests for Revolving Borrowings..............................12
SECTION 2.04. Competitive Bid Procedure......................................13
SECTION 2.05. Funding of Borrowings..........................................14
SECTION 2.06. Repayment of Borrowings; Evidence of Debt......................15
SECTION 2.07. Interest Elections.............................................15
SECTION 2.08. Termination, Reduction and Extension of Commitments............16
SECTION 2.09. Prepayment of Loans............................................19
SECTION 2.10. Fees...........................................................19
SECTION 2.11. Interest.......................................................20
SECTION 2.12. Alternate Rate of Interest.....................................20
SECTION 2.13. Increased Costs................................................21
SECTION 2.14. Break Funding Payments.........................................22
SECTION 2.15. Taxes..........................................................22
SECTION 2.16. Payments Generally; Pro Rata Treatment; Sharing of Setoffs.....23
SECTION 2.17. Mitigation Obligations; Replacement of Lenders.................24

ARTICLE III

Representations and Warranties

SECTION 3.01. Corporate Existence and Standing...............................25
SECTION 3.02. Authorization; No Violation....................................25
SECTION 3.03. Governmental Consents..........................................25
SECTION 3.04. Validity.......................................................25
SECTION 3.05. Litigation.....................................................25
{PAGE}

Contents, p. 2


SECTION 3.06. Financial Statements; No Material Adverse Change................25
SECTION 3.07. Investment Company Act..........................................25
SECTION 3.08. Regulation U....................................................26
SECTION 3.09. Environmental Matters...........................................26
SECTION 3.10. Disclosure......................................................26
SECTION 3.11 Subsidiary Guarantors...........................................26
SECTION 3.12 Solvency........................................................26

ARTICLE IV

Conditions

SECTION 4.01. Effective Date.................................................27
SECTION 4.02. Each Credit Event..............................................27

ARTICLE V

Affirmative Covenants

SECTION 5.01. Payment of Taxes, Etc. ........................................28
SECTION 5.02. Maintenance of Insurance.......................................28
SECTION 5.03. Preservation of Existence, Etc. ...............................28
SECTION 5.04. Compliance with Laws, Etc. ....................................28
SECTION 5.05. Keeping of Books...............................................28
SECTION 5.06. Inspection.....................................................28
SECTION 5.07. Reporting Requirements.........................................28
SECTION 5.08. Use of Proceeds................................................30
SECTION 5.09. Guarantee Requirement..........................................30

ARTICLE VI

Negative Covenants

SECTION 6.01. Subsidiary Debt................................................30
SECTION 6.02. Liens, Etc. ...................................................30
SECTION 6.03. Sale and Leaseback Transactions................................33
SECTION 6.04. Merger, Etc. ..................................................33
SECTION 6.05. Change in Business.............................................33
SECTION 6.06. Certain Restrictive Agreements.................................33
SECTION 6.07. Leverage Ratio.................................................33
SECTION 6.08. Interest Coverage Ratio........................................33

ARTICLE VII

Events of Default.............................................................35

{PAGE}

Contents, p. 3


ARTICLE VIII

The Administrative Agent......................................................37

ARTICLE IX

Miscellaneous

SECTION 9.01. Notices........................................................39
SECTION 9.02. Waivers; Amendments............................................39
SECTION 9.03. Expenses; Indemnity; Damage Waiver.............................40
SECTION 9.04. Successors and Assigns.........................................41
SECTION 9.05. Survival.......................................................42
SECTION 9.06. Counterparts; Integration; Effectiveness.......................43
SECTION 9.07. Severability...................................................43
SECTION 9.08. Right of Setoff................................................43
SECTION 9.09. Governing Law; Jurisdiction; Consent to Service of Process.....43
SECTION 9.10. WAIVER OF JURY TRIAL...........................................44
SECTION 9.11. Headings.......................................................44
SECTION 9.12. Confidentiality................................................44
SECTION 9.13. Conversion of Currencies.......................................44
SECTION 9.14. Release of Guarantors..........................................44

SCHEDULES:

Schedule 1.01 -- Subsidiary Guarantors
Schedule 2.01 -- Lenders and Commitments
Schedule 2.01(b) -- Departing Lenders
Schedule 2.16 -- Payment Instructions
Schedule 6.01 -- Debt of Material Subsidiaries
Schedule 6.02 -- Security Interests

EXHIBITS:

Exhibit A -- Form of Assignment and Acceptance
Exhibit B -- Form of Subsidiary Guarantee Agreement
Exhibit C -- Form of Indemnity, Subrogation and Contribution Agreement
Exhibit D-1 -- Form of Opinion of Counsel for the Company

 

End of Preview

 

Home        Intelligence        Services        Subscriptions        News        About Us

Contact Us       Terms of Use       Resend Documents       Shopping Cart

Copyright © 2008 The Consus Group LLC